Select Equity Group, L.P. 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-13 8:07 pm Sale |
2022-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 2,524,793 1.900% |
-8,996,782![]() (-78.09%) |
Filing |
2022-11-10 4:41 pm Sale |
2022-10-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 11,521,575 8.800% |
-9,020,928![]() (-43.91%) |
Filing |
2022-02-11 5:38 pm Purchase |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 20,542,503 15.600% |
5,607,666![]() (+37.55%) |
Filing |
2021-11-09 5:07 pm Purchase |
2021-10-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 14,934,837 11.400% |
14,934,837![]() (New Position) |
Filing |